Beruflich Dokumente
Kultur Dokumente
R E S E A R C H
& R E V I E W
A publication from Lonzagroup —The world’s leading raw material supplier of L-Carnitine Issue 4
INTRODUCTION
Genetics Environment
Obesity is a serious health problem in
Western societies affecting more than
Metabolism Food Density
30% of the adult population in the Hormones Physical Activity
United States. A common parameter for Others Overweight Others
5
% Individuals Showing
4
Complications
0
Weight Loss Decrease in BMI
■ L-Carnitine + Diet + Exercise Take Note...
■ Diet + Exercise
Figure 3: In an open, non controlled study, 100 obese people (aver-
age body weight 213.8 lb, 27 to 64 years of age) received diet (1200
The only way to shed that
kcal/day) or diet supplemented with L-Carnitine (3 g/day for 4
weeks) in conjunction with moderate exercise. Weight loss (kg; 1 lb=
extra weight is by burning
0.45 kg) and decrease in BMI (BMI = body weight/(height)2) are
shown following treatment with L-Carnitine. The difference in excessive fat.
weight loss between L-Carnitine supplementation and control was
significant9.
2
R E S E A R C H
& R E V I E W
200
❸ L-Carnitine supplementation has protein sparing effects:
the enhancement of b-oxidation reduces the breakdown 150
of branched chain amino acids by an internal feedback 100
mechanism and 50
❹ promotes protein synthesis resulting in a leaner body4. 0
❺ Supplemental L-Carnitine alleviates recycling of CoA: it -50
increases the levels of mitochondrial free CoA by shut- L-Carnitine Control
-100
tling the short chain acyl groups from inside the mito
Figure 5 shows the lean body mass change (g) from the beginning to
chondria to the cytosol12. the end of the study in dogs14 and cats15.
❻ The improved availability of mitochondrial free CoA
favors the continuation of b-oxidation as the released This muscle gain shown in both studies is important because leaner
CoA is made available to the Krebs Cycle which is linked animals are more likely to maintain their ideal body weight and
with the electron transport chain where energy is ulti- less likely to become overweight again.Through these series of
mately produced. research studies, Hill’s has identified a level of L-Carnitine neces-
❼ The increased availability of amino acids supports hepatic sary to provide benefits of optimal fat metabolism while main-
gluconeogenesis which results in an enhanced glucose taining lean muscle.
supply to the brain. As a consequence of the above, In fact, because this is such a weighty problem, Hill’s Pet Nutrition
L-Carnitine may induce appetite suppression and increase
created the Hill’s® Pet Fit™ Challenge to encourage pet owners
the resting metabolic rate (RMR) which represents the
rate at which the body burns energy to sustain bodily to help manage their overweight pet’s condition.This easy-to-
functions. It is noteworthy, that a low RMR is a predictor follow weight control program was designed to help pets lose
of body weight gain as it is inversely related to body weight, helping to regain their ideal weight, and thereby achieve
weight13. better health and possibly even extend their lives. For more
information, visit the Pet Fit™ website at www.petfit.com.
3
Switzerland
CH-4002 Basel
P.O. Box
LONZA Ltd.
USA
Fair Lawn, NJ 07410
17-17 Route 208
LONZA Inc.
L-CARNITINE
Lonzagroup, the leading manufacturer and supplier of the bulk
and so to conclude... dietary supplement L-Carnitine, is the only supplier who can guar-
antee 100% pure, natural L-Carnitine- totally free from toxic
Studies in obese people have shown that only low calorie diets together D-Carnitine. Our L-Carnitine is Kosher certified and is found in
with physical exercise will guarantee long term weight loss. Both of these infant formula, multivitamins and a wide variety of health products.
measures induce a deficiency in L-Carnitine. Suboptimal levels of L-Carnitine Lonzagroup offers the following four forms of L-Carnitine:
L-Carnitine USP Free Base, our unique and patented L-Carnitine
may also cause fatigue and strongly impair b-oxidation. Clinical studies L-Tartrate (US Patent 5,073,376 and other international patents),
demonstrated the effectiveness of supplementary L-Carnitine for weight L-Carnitine Magnesium Citrate (US Patent 5,071,874 and other
management, the improvement of exercise performance and maintenance international patents) and Acetyl-L-Carnitine.
of a healthy heart (see Newsletter 2 & 3, available at www.carnitine.com). L-CARNIPURE® and the L-CARNIPURE® logo are registered
trademarks of LONZA Ltd. and your assurance of outstanding
With the above information on hand, it is anticipated that L-Carnitine is quality.
the nutritional supplement of choice for successful weight management. For more information:
Worldwide: In the USA:
References LONZA Ltd., Basel, Switzerland
Tel: +41-61-316-8111
LONZA Inc., Fair Lawn, NJ
Tel: 1-800-955-7426
1. Krauss, R.M. and Eckel, R.H. (1998). N. Engl. 9. Lurz, R. and Fischer, R. (1998).
Aerztezeitschrift für Naturheilverfahren Fax: +41-61-316-8446 Fax: 1-201-794-2695
J. Med. 338: 1156.
2. Bennet, P.H. (1990) in: Rifkin, H. and Porte, 39:12. E-mail: carnitine@lonza.com E-mail: carnitine@lonza-us.com
J.D. (eds) Diabtes Mellitus. New York, 10. Kaats, G.R. (1992). Cur.Ther. Res. 51: 261. Or visit our website at www.carnitine.com
Elsevier Science Publishing Co.: 357. 11. Cerrettelli, P. & Marconi, C. (1990). Intl. J.
3. Owen, K. et al (1996). Swine Day Rep. I. Sports Med. 11: 1. International offices in: Barcelona, Breda, Budapest, Cheltenham,
4. Owen, K. et al (1994). Swine Day. 161. 12. Leibovitz, B.E. (1993). L-Carni-tine. Hong Kong, Kourim, Levallois-Perret, Milan, Moscow,Tokyo,
5. Feller, A.G. & Rudmann, D. (1988). J. of Nutr. LONZA publication. Warsaw,Wuppertal
118: 541. 13. Ravussin, E. et al (1988). N. Engl. J. Med. Note: This document is an overview of published scientific information on L-Carnitine
6. Davis., A.T. et al (1990) J. Am. Coll. Nutr. 318:467. and published scientific information on clinical and nutritional trials with L-Carnitine
9:261. 14. Gross, K.L. et al (1998). J. Animal Sci. 76 and its derivatives.The statements in this document have not been evaluated by any
Food and Drug Administration. No claims are made herein for any particular product
7. Friedman, M.I. et al (1990). Am. J. Physiol. (1): 175. or that any product is intended to diagnose, treat, cure, or prevent any disease.The
258: 216. 15. Jewell, D. E. and P. W.Toll. (1998). Adapted recommended use for L-Carnitine is as a nutrient or dietary supplement. No state-
8. Sufeng, Z. et al (1997). Acta Nutr. Sin. from "Obesity: Weight Management in Cats ment is intended or should be construed as a recommendation to infringe any
19: 146. and Dogs". Hill’s Pet Nutrition. existing patent.The information contained herein is believed to be correct and
corresponds to the latest state of scientific and technical knowledge.